BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lovastatin
,
rs4950928
,
LEP
,
Apoptosis
,
HIV infection
,
Kidney
,
Hematopoietic cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Signal recognition particle
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Lung cancer A549 cells and xenograft with CRISPR-CAS9 mediated HDLBP knockout
Hippocampi from chromosome 1 hybrid mouse strains
Explore Curated Studies Results
Literature
Most Relevant Literature
Dynamic switch of the signal recognition particle from scanning to targeting.
A network of cytosolic factors targets SRP-independent proteins to the endoplasmic reticulum.
Is there a twist in the Escherichia coli signal recognition particle pathway?
Decreased dicer expression enhances SRP-mediated protein targeting.
Network models reveal stability and structural rearrangement of signal recognition particle.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
Study of M5049 in DM and PM Participants (NEPTUNIA)
A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants W…
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ